Hubei Guangji Pharmaceutical Co Ltd (000952) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hubei Guangji Pharmaceutical Co Ltd (000952) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥22.38 Million ≈ $3.27 Million USD) by net assets (CN¥963.20 Million ≈ $140.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 000952 market cap for the company's overall valuation and market capitalisation.
Hubei Guangji Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Hubei Guangji Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Hubei Guangji Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hubei Guangji Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 000952 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bravo Mining Corp
V:BRVO
|
-0.005x |
|
Syncmold Enterprise Corp
TW:1582
|
0.036x |
|
TianJin JinRong TianYu Precision Machinery Inc.
SHE:300988
|
0.019x |
|
Regal Asian Investments Ltd
AU:RG8
|
N/A |
|
Wuhan Citms Technology Co Ltd
SHG:688038
|
-0.054x |
|
Paysafe Ltd
NYSE:PSFE
|
0.114x |
|
Pinlive Foods Co Ltd
SHE:300892
|
0.009x |
|
Denny’s Corp
NASDAQ:DENN
|
-0.489x |
Annual Cash Flow Conversion Efficiency for Hubei Guangji Pharmaceutical Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Hubei Guangji Pharmaceutical Co Ltd from 1998 to 2025. View current stock price of Hubei Guangji Pharmaceutical Co Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥626.85 Million ≈ $91.73 Million |
CN¥60.43 Million ≈ $8.84 Million |
0.096x | +15730.22% |
| 2024-12-31 | CN¥1.08 Billion ≈ $157.48 Million |
CN¥655.36K ≈ $95.90K |
0.001x | +100.57% |
| 2023-12-31 | CN¥1.39 Billion ≈ $203.76 Million |
CN¥-148.96 Million ≈ $-21.80 Million |
-0.107x | -454.02% |
| 2022-12-31 | CN¥1.49 Billion ≈ $218.30 Million |
CN¥45.08 Million ≈ $6.60 Million |
0.030x | -42.24% |
| 2021-12-31 | CN¥1.45 Billion ≈ $212.30 Million |
CN¥75.91 Million ≈ $11.11 Million |
0.052x | -40.15% |
| 2020-12-31 | CN¥1.37 Billion ≈ $199.84 Million |
CN¥119.38 Million ≈ $17.47 Million |
0.087x | -41.54% |
| 2019-12-31 | CN¥964.30 Million ≈ $141.11 Million |
CN¥144.20 Million ≈ $21.10 Million |
0.150x | -43.08% |
| 2018-12-31 | CN¥880.96 Million ≈ $128.91 Million |
CN¥231.44 Million ≈ $33.87 Million |
0.263x | +12.42% |
| 2017-12-31 | CN¥765.24 Million ≈ $111.98 Million |
CN¥178.83 Million ≈ $26.17 Million |
0.234x | -7.80% |
| 2016-12-31 | CN¥659.18 Million ≈ $96.46 Million |
CN¥167.07 Million ≈ $24.45 Million |
0.253x | +490.58% |
| 2015-12-31 | CN¥513.86 Million ≈ $75.19 Million |
CN¥-33.35 Million ≈ $-4.88 Million |
-0.065x | +56.09% |
| 2014-12-31 | CN¥505.45 Million ≈ $73.96 Million |
CN¥-74.69 Million ≈ $-10.93 Million |
-0.148x | -214.15% |
| 2013-12-31 | CN¥735.04 Million ≈ $107.56 Million |
CN¥95.16 Million ≈ $13.92 Million |
0.129x | -8.91% |
| 2012-12-31 | CN¥760.05 Million ≈ $111.22 Million |
CN¥108.02 Million ≈ $15.81 Million |
0.142x | +49.90% |
| 2011-12-31 | CN¥863.60 Million ≈ $126.37 Million |
CN¥81.88 Million ≈ $11.98 Million |
0.095x | +3.11% |
| 2010-12-31 | CN¥839.35 Million ≈ $122.82 Million |
CN¥77.18 Million ≈ $11.29 Million |
0.092x | +408.50% |
| 2009-12-31 | CN¥816.91 Million ≈ $119.54 Million |
CN¥-24.35 Million ≈ $-3.56 Million |
-0.030x | -110.96% |
| 2008-12-31 | CN¥811.28 Million ≈ $118.72 Million |
CN¥220.70 Million ≈ $32.30 Million |
0.272x | -44.85% |
| 2007-12-31 | CN¥673.00 Million ≈ $98.48 Million |
CN¥331.98 Million ≈ $48.58 Million |
0.493x | +87.08% |
| 2006-12-31 | CN¥477.68 Million ≈ $69.90 Million |
CN¥125.95 Million ≈ $18.43 Million |
0.264x | +158.99% |
| 2005-12-31 | CN¥531.76 Million ≈ $77.81 Million |
CN¥54.14 Million ≈ $7.92 Million |
0.102x | +1705.73% |
| 2004-12-31 | CN¥523.19 Million ≈ $76.56 Million |
CN¥-3.32 Million ≈ $-485.42K |
-0.006x | +78.81% |
| 2003-12-31 | CN¥514.56 Million ≈ $75.30 Million |
CN¥-15.40 Million ≈ $-2.25 Million |
-0.030x | -119.91% |
| 2002-12-31 | CN¥506.86 Million ≈ $74.17 Million |
CN¥76.20 Million ≈ $11.15 Million |
0.150x | +426.75% |
| 2001-12-31 | CN¥486.87 Million ≈ $71.24 Million |
CN¥-22.40 Million ≈ $-3.28 Million |
-0.046x | -145.62% |
| 2000-12-31 | CN¥481.54 Million ≈ $70.46 Million |
CN¥48.57 Million ≈ $7.11 Million |
0.101x | -33.92% |
| 1999-12-31 | CN¥449.30 Million ≈ $65.75 Million |
CN¥68.57 Million ≈ $10.03 Million |
0.153x | +291.61% |
| 1998-12-31 | CN¥191.95 Million ≈ $28.09 Million |
CN¥-15.29 Million ≈ $-2.24 Million |
-0.080x | -- |
About Hubei Guangji Pharmaceutical Co Ltd
Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, pharmaceutical preparations, and feed additives in China and internationally. The company also exports its products. Hubei Guangji Pharmaceutical Co., Ltd. was founded in 1969 and is based in Wuxue, China.